Fluoxetine impairs GABAergic signaling in hippocampal slices from neonatal rats

Frontiers in Cellular Neuroscience

Volumn , Issue APR, 2013, Pages

  Caiati, Maddalena Delma ^a,b   Cherubini, Enrico ^a  

^a SISSA   (Italy)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Fluoxetine; GDPs; Immature hippocampus; Spontaneous action potential dependent release of GABA; Spontaneous firing of principal cells and interneurons

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CANNABINOID RECEPTOR; FLUOXETINE;

ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; GABAERGIC TRANSMISSION; GIANT DEPOLARIZING POTENTIAL; HIPPOCAMPAL CA3 REGION; INTERNEURON; NERVE CELL EXCITABILITY; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVE CONDUCTION; NERVOUS SYSTEM POTENTIAL; NONHUMAN; RAT; SIGNAL TRANSDUCTION;

EID: 84876453518     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2013.00063     Document Type: Article

References (50)

1. Allene C, Picardo MA, Becq H, Miyoshi G, Fishell G, Cossart R (2012). Dynamic changes in interneuron morphophysiological properties mark the maturation of hippocampal network activity. J Neurosci 32:6688-6698.
2. Ben-Ari Y, Cherubini E, Corradetti R, Gaiarsa JL (1989). Giant synaptic potentials in immature rat CA3 hippocampal neurones. J Physiol (Lond) 416:303-325.
3. Ben-Ari Y, Khalilov I, Kahle KT, Cherubini E (2012). The GABA excitatory/inhibitory shift in brain maturation and neurological disorders. Neuroscientist 18:467-486.
4. Bolea S, Avignone E, Berretta N, Sanchez-Andres JV, Cherubini E (1999). Glutamate controls the induction of GABA-mediated giant depolarizing potentials through AMPA receptors in neonatal rat hippocampal slices. J Neurophysiol 81:2095-2102.
5. Bonifazi P, Goldin M, Picardo MA, Jorquera I, Cattani A, Bianconi G, Represa A, Ben-Ari Y, Cossart R (2009). GABAergic hub neurons orchestrate synchrony in developing hippocampal networks. Science 326:1419-1424.
6. Caiati MD, Sivakumaran S, Cherubini E (2010). In the developing rat hippocampus, endogenous activation of presynaptic kainate receptors reduces GABA release from mossy fiber terminals. J Neurosci 30:1750-1759.
7. Caiati MD, Sivakumaran S, Lanore F, Mulle C, Richard E, Verrier D, Marsicano G, Miles R, Cherubini E (2012). Developmental regulation of CB1-mediated spike-time dependent depression at immature mossy fiber-CA3 synapses. Sci Rep 2:285. doi: 10.1038/srep00285.
8. Castrén E (2005). Is mood chemistry? Nat Rev Neurosci 6:241-246.
9. Cherubini E, Gaiarsa JL, Ben-Ari Y (1991). GABA: an excitatory transmitter in early postnatal life. Trends Neurosci 14:515-519.
10. Cossart R (2011). The maturation of cortical interneuron diversity: how multiple developmental journeys shape the emergence of proper network function. Curr Opin Neurobiol 21:160-168.
11. Davanzo R, Copertino M, De Cunto A, Minen F, Amaddeo A (2011). Antidepressant drugs and breastfeeding: a review of the literature. Breastfeed Med 6:89-98.
12. Deák F, Lasztóczi B, Pacher P, Petheö GL, Valéria Kecskeméti, Spät A (2000). Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells. Neuropharmacology 39:1029-1036.
13. De la Prida LM, Huberfeld G, Cohen I, Miles R (2006). Threshold behavior in the initiation of hippocampal population bursts. Neuron 49:131-142.
14. Freund TF, Katona I (2007). Perisomatic inhibition. Neuron 56:33-42.
15. Heikkine T, Ekblad U, Laine K (2002). Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta. BJOG 109:1003-1008.
16. Henkel AW, Welzel O, Groemer TW, Tripal P, Rotter A, Kornhuber J (2010). Fluoxetine prevents stimulation-dependent fatigue of synaptic vesicle exocytosis in hippocampal neurons. J Neurochem 114:697-705.
17. Henry ME, Schmidt ME, Hennen J, Villafuerte RA, Butman ML, Tran P, Kerner LT, Cohen B, Renshaw PF (2005). A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: A 19-F MRS study. Neuropsychopharmacology 30:1576-1583.
18. Igelström KM, Heyward PM (2012). The antidepressant drug fluoxetine inhibits persistent sodium currents and seizure-like events. Epilepsy Res 101:174-181.
19. Inoue T, Hashimoto S, Tsuchiya K, Izumi T, Ohmori T, Koyama T (1996). Effect of citalopram, a selective serotonin reuptake inhibitor, on the acquisition of conditioned freezing. Eur J Pharmacol 311:1-6.
20. Karson CN, Newton JE, Livingston R, Jolly JB, Cooper TB, Sprigg J, Komoroski RA (1993). Human brain fluoxetine concentrations. J Neuropsychiatry Clin Neurosci 5:322-329.
21. Kasyanov AM, Safiulina VF, Voronin LL, Cherubini E (2004). GABA-mediated giant depolarizing potentials as coincidence detectors for enhancing synaptic efficacy in the developing hippocampus. Proc Natl Acad Sci USA 101:3967-3972
22. Klausberger T, Somogyi P (2008). Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science 321:53-57.
23. Kobayashi K, Ikeda Y, Haneda E, Suzuki H (2008). Chronic fluoxetine bidirectionally modulates potentiating effects of serotonin on the hippocampal mossy fiber synaptic transmission. J Neurosci 28:6272-6280.
24. Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455:894-902.
25. Leinekugel X, Khazipov R, Cannon R, Hirase H, Ben Ari Y, Buzsaki G (2002). Correlated bursts of activity in the neonatal hippocampus in vivo. Science 296:2049-2052.
26. Lenkey N, Karoly R, Kiss JP, Szasz BK, Vizi ES, Mike A (2006). The mechanism of activity-dependent sodium channel inhibition by the antidepressants fluoxetine and desipramine. Mol Pharmacol 70:2052-2063.
27. Luscher B, Shen Q, Sahir N (2011). The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 16:383-406
28. Madeja M, Margineanu DG, Gorji A, Siep E, Boerrigter P, Klitgaard H, Speckmann EJ (2003). Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action? Neuropharmacology 45:661-671.
29. Marchionni I, Omrani A, Cherubini E (2007). In the developing rat hippocampus a tonic GABAA-mediated conductance selectively enhances the glutamatergic drive of principal cells. J Physiol (Lond) 581:515-528.
30. Maya Vetencourt JF, Sale A, Viegi A, Baroncelli L, De Pasquale R, O'Leary OF, Castrén E, Maffei L (2008). The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 320:385-388.
31. Maya Vetencourt JF, Tiraboschi E, Spolidoro M, Castrén E, Maffei L (2011). Serotonin triggers a transient epigenetic mechanism that reinstates adult visual cortex plasticity in rats. Eur J Neurosci 33:49-57
32. Maya-Vetencourt JF, Tiraboschi E, Greco D, Restani L, Cerri C, Auvinen P, Maffei L, Castrén E (2012). Experience-dependent expression of NPAS4 regulates plasticity in adult visual cortex. J Physiol (Lond) 590: 4777-4787.
33. McIntyre RS (2010). Pharmacology and efficacy of asenapine for manic and mixed states in adults with bipolar disorder. Expert Rev Neurother 10:645-649.
34. Méndez P, Pazienti A, Szabó G, Bacci A (2012). Direct alteration of a specific inhibitory circuit of the hippocampus by antidepressants. J Neurosci 32:16616-16628.
35. Menendez de la Prida L, Bolea S, Sanchez-Andres JV (1998). Origin of the synchronized network activity in the rabbit developing hippocampus. Eur J Neurosci 10:899-906.
36. Mohajerani MH, Sivakumaran S, Zacchi P, Aguilera P, Cherubini E (2007). Correlated network activity enhances synaptic efficacy via BDNF and the ERK pathway at immature CA3 CA1 connections in the hippocampus. Proc Natl Acad Sci USA 104:13176-13181
37. Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, Koren G (2002). Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 159:1889-1895.
38. Oberlander TF, Gingrich JA, Ansorge MS (2009). Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin Pharmacol Ther 86:672-677.
39. Olivier JD, Blom T, Arentsen T, Homberg JR (2011a). The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: A review. Prog Neuropsychopharmacol Biol Psychiatry 35:1400-1408.
40. Olivier JD, Vallès A, van Heesch F, Afrasiab-Middelman A, Roelofs JJ, Jonkers M, Peeters EJ, Korte-Bouws GA, Dederen JP, Kiliaan AJ, Martens GJ, Schubert D, Homberg JR (2011b). Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring. Psychopharmacology (Berl) 217:419-432.
41. Pawluski JL, Rayen I, Niessen NA, Kristensen S, van Donkelaar EL, Balthazart J, Steinbusch HW, Charlier TD (2012). Developmental fluoxetine exposure differentially alters central and peripheral measures of the HPA system in adolescent male and female offspring. Neuroscience 220:131-141.
42. Pfenninger KH, Laurino L, Peretti D, Wang X, Rosso S, Morfini G, Cáceres A, Quiroga S (2003). Regulation of membrane expansion at the nerve growth cone. J Cell Sci 116:1209-1217.
43. Picardo MA, Guigue P, Bonifazi P, Batista-Brito R, Allene C, Ribas A, Fishell G, Baude A, Cossart R (2011). Pioneer GABA cells comprise a subpopulation of hub neurons in the developing hippocampus. Neuron 71:695-709.
44. Robinson RT, Drafts BC, Fisher JL (2003). Fluoxetine increases GABA(A) receptor activity through a novel modulatory site. J Pharmacol Exp Ther 304:978-984.
45. Safiulina VF, Zacchi P, Taglialatela M, Yaari Y, Cherubini E (2008). Low expression of Kv7/M channels facilitates intrinsic and network bursting in the developing rat hippocampus. J Physiol (Lond) 586:5437-5453.
46. Sipilä ST, Huttu K, Soltesz I, Voipio J, Kaila K (2005). Depolarizing GABA acts on intrinsically bursting pyramidal neurons to drive giant depolarizing potentials in the immature hippocampus. J Neurosci 25:5280-5289.
47. Traboulsie A, Chemin J, Kupfer E, Nargeot J, Lory P (2006). T-type calcium channels are inhibited by fluoxetine and its metabolite norfluoxetine. Mol Pharmacol 69:1963-1968.
48. Wong DT, Horng JS, Bymaster FP, Hauser KL, Molloy BB (1974). A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. Life Sci 15:471-479.
49. Wong DT, Bymaster FP, Engleman EA (1995). Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci 57:411-441
50. Yeung SY, Millar JA, Mathie A (1999). Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetine. Br J Pharmacol 128:1609-1615.